# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA952417 | F | Antagonist activity at T type calcium channel Cav3.3 alpha1i at -60 mV by FLIPR assay | 7 | ALA1157496 | assay format | Scientific Literature | ||
2. | ALA952418 | F | Antagonist activity at T type calcium channel Cav3.3 alpha1i at -20 mV by FLIPR assay | 7 | ALA1157496 | assay format | Scientific Literature | ||
3. | ALA1033088 | B | Inhibition of T-type calcium channel alpha1I by FLIPR | 27 | ALA1140166 | single protein format | Scientific Literature | ||
4. | ALA1033103 | B | Inhibition of human T-type Cav3.3 expressed in HEK293 cells at -100mV holding potential by whole cell patch clamp assay | Homo sapiens | 1 | ALA1140166 | cell-based format | Scientific Literature | |
5. | ALA1033104 | B | Inhibition of human T-type Cav3.3 expressed in HEK293 cells at -80mV holding potential by whole cell patch clamp assay | Homo sapiens | 1 | ALA1140166 | cell-based format | Scientific Literature | |
6. | ALA1219199 | B | Inhibition of T-type Cav3.3 channel | 2 | ALA1212879 | single protein format | Scientific Literature | ||
7. | ALA1225387 | F | Antagonist activity at Cav3.3 alpha1i by depolarized FLIPR assay | 37 | ALA1221274 | assay format | Scientific Literature | ||
8. | ALA1225409 | F | Antagonist activity at Cav3.3 alpha1i by hyperpolarized FLIPR assay | 3 | ALA1221274 | assay format | Scientific Literature | ||
9. | ALA1646504 | B | Binding affinity to T-type alpha1I calcium channel | 1 | ALA1641559 | single protein format | Scientific Literature | ||
10. | ALA1686262 | B | Binding affinity to Cav3.3 alpha1i | 2 | ALA1681710 | single protein format | Scientific Literature | ||
11. | ALA1686263 | F | Antagonist activity at Cav3.3 alpha1i expressed in HEK293 cells by depolarized FLIPR assay | 35 | ALA1681710 | cell-based format | Scientific Literature | ||
12. | ALA1686269 | F | Antagonist activity at Cav3.3 alpha1i expressed in HEK293 cells at -80 mV by standard voltage-clamp electrophysiology assay | 1 | ALA1681710 | cell-based format | Scientific Literature | ||
13. | ALA1686270 | F | Antagonist activity at Cav3.3 alpha1i expressed in HEK293 cells at -100 mV by standard voltage-clamp electrophysiology assay | 1 | ALA1681710 | cell-based format | Scientific Literature | ||
14. | ALA2154388 | F | Antagonist activity at Cav3.3 at -100 mV holding potential by whole cell patch clamp analysis | 1 | ALA2150960 | assay format | Scientific Literature | ||
15. | ALA2154389 | F | Antagonist activity at Cav3.3 at -80 mV holding potential by whole cell patch clamp analysis | 1 | ALA2150960 | assay format | Scientific Literature | ||
16. | ALA3855322 | B | Inhibition of T-type calcium channel Cav3.3 (unknown origin) expressed in HEK293 cells assessed as calcium influx by Fluo-4-AM dye-based FLIPR assay | Homo sapiens | 3 | ALA3853331 | cell-based format | Scientific Literature | |
17. | ALA3855323 | B | Inhibition of human T-type calcium channel Cav3.3 expressed in CHO cells assessed as inhibition of calcium tail current at -60 mV holding potential measured after 150 secs by QPatch assay | Homo sapiens | 1 | ALA3853331 | cell-based format | Scientific Literature | |
18. | ALA3855336 | B | Inhibition of human T-type calcium channel Cav3.3 expressed in CHO cells assessed as inhibition of calcium tail current at -90 mV holding potential measured after 150 secs by QPatch assay | Homo sapiens | 1 | ALA3853331 | cell-based format | Scientific Literature | |
19. | ALA3865191 | B | Inhibition of CaV 3.3 channel (unknown origin) expressed in HEK293 cells by FLEPR Ca2+ flux assay | Homo sapiens | 1 | ALA3864167 | cell-based format | Scientific Literature | |
20. | ALA3865194 | B | Inhibition of human CaV 3.3 by manual patch clamp assay | Homo sapiens | 1 | ALA3864167 | assay format | Scientific Literature |